Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Clin Exp Nephrol ; 24(7): 590-597, 2020 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-32185544

RESUMEN

BACKGROUND: Responsiveness to erythropoietin-stimulating agents (ESAs) is important for anemia management in chronic kidney disease (CKD). We assessed the effects of a continuous erythropoietin receptor activator (CERA) on renoprotection beyond anemia management and the correlation between the responsiveness to ESAs and oxidative stress markers in CKD. METHODS: This single-center, prospective, observational study was conducted over 24 months. We administered CERA to 35 non-dialysis patients with hemoglobin (Hb) < 11 g/dL and examined the results of the serum diacron-reactive oxygen metabolite (dROMs) test for oxidative stress markers and biological antioxidant potential (BAP) test for antioxidant markers. We then examined the renoprotective effects of CERA and the responsiveness to CERA. RESULTS: Eighteen patients experienced renal events (doubling of serum creatinine levels, decreased estimated glomerular filtration rate to < 6.0 mL/min/1.73 m2, or initiation of renal replacement therapy), seventeen of which survived. Kaplan-Meier analysis showed that responsiveness to CERA during the initial 3-month treatment period was a good predictor of renal events. Moreover, a high response to CERA during the 3 months independently suppressed renal events (hazard ratio, 0.344). High BAP levels at baseline were significantly associated with high responsiveness to CERA during the initial 3-month treatment period. CONCLUSION: Responsiveness to CERA during the first 3 months was an important indicator of CKD progression. Moreover, BAP test results determined responsiveness to CERA. This is the first report to show how antioxidant levels can be a potential marker of CERA's ability to control anemia in CKD patients.


Asunto(s)
Anemia/tratamiento farmacológico , Antioxidantes/metabolismo , Eritropoyetina/uso terapéutico , Hematínicos/uso terapéutico , Polietilenglicoles/uso terapéutico , Especies Reactivas de Oxígeno/sangre , Insuficiencia Renal/fisiopatología , Anciano , Anciano de 80 o más Años , Anemia/etiología , Biomarcadores/sangre , Creatinina/sangre , Progresión de la Enfermedad , Eritropoyetina/administración & dosificación , Femenino , Tasa de Filtración Glomerular , Hematínicos/administración & dosificación , Hemoglobinas/metabolismo , Humanos , Masculino , Persona de Mediana Edad , Estrés Oxidativo , Polietilenglicoles/administración & dosificación , Pronóstico , Estudios Prospectivos , Insuficiencia Renal/complicaciones , Insuficiencia Renal/terapia , Resultado del Tratamiento
2.
Arch Phys Med Rehabil ; 91(8): 1210-7, 2010 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-20684901

RESUMEN

OBJECTIVE: To investigate the effects of hemiparesis on handwriting using a 3-dimensional movement analyzer. DESIGN: Comparative case study. SETTING: Ambulatory care clinic. PARTICIPANTS: Right-handed patients (n=25; mean age +/- SD, 62.3+/-10y) with mild right hemiparesis secondary to subcortical stroke, and age-matched (n=10; 65.6+/-13y) and age-unmatched (n=15; 32.4+/-10y) control subjects. INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Time required to write a Japanese character of 2 different sizes and average speed of handwriting at the pen tip. Average radii of tracks of the moving pen tip, metacarpal head of the index finger, and distal end of the forearm during writing. Correlation coefficients of the instantaneous speed-time graph of the pen tip with that of the index finger and with that of the distal forearm during writing. RESULTS: Time for writing with the hemiparetic right hand was longer than that with the unaffected left hand (P=.05 approximately .03), while it was shorter in healthy control subjects (P=.07 approximately .05). In contrast with the left-hand writing, the track radius of the pen tip of the right-hand writing in patients with hemiparesis with normal joint position sense was significantly larger than that of the finger or distal forearm (P=.01). The finding was the same as in the young and elderly control subjects. This right-left difference disappeared in the patients with hemiparesis with position sense impairment. The correlation coefficient of speed between the pen tip and the finger was larger in right-hand than left-hand writing in the control and sensory-normative patients with hemiparesis even though the difference was significant only in the healthy elderly subjects (P=.03). Irrespective of the right or left hand use, the correlation coefficient between the pen tip and the finger or distal forearm significantly increased as the character size increased (P=.03 approximately 6 x10(-6)) in all subjects and patients. However, this size-related difference was less significant in the patients with sensory impairment. CONCLUSIONS: The characteristics of handwriting movement by the dominant hand were preserved in patients with mild dominant-hand hemiparesis when joint position sense was normative but were lost in those with position sense impairment.


Asunto(s)
Escritura Manual , Movimiento , Paresia/fisiopatología , Accidente Cerebrovascular/complicaciones , Adulto , Anciano , Fenómenos Biomecánicos , Estudios de Casos y Controles , Femenino , Lateralidad Funcional , Humanos , Masculino , Persona de Mediana Edad , Paresia/etiología , Paresia/rehabilitación , Modalidades de Fisioterapia , Índice de Severidad de la Enfermedad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...